DE69331652T2 - Azetidinonverbindung und Verfahren zu ihrer Herstellung - Google Patents

Azetidinonverbindung und Verfahren zu ihrer Herstellung

Info

Publication number
DE69331652T2
DE69331652T2 DE69331652T DE69331652T DE69331652T2 DE 69331652 T2 DE69331652 T2 DE 69331652T2 DE 69331652 T DE69331652 T DE 69331652T DE 69331652 T DE69331652 T DE 69331652T DE 69331652 T2 DE69331652 T2 DE 69331652T2
Authority
DE
Germany
Prior art keywords
substituent
preparation
azetidinone compound
oxygen atom
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69331652T
Other languages
English (en)
Other versions
DE69331652D1 (de
Inventor
Tameo Iwasaki
Kazuhiko Kondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of DE69331652D1 publication Critical patent/DE69331652D1/de
Application granted granted Critical
Publication of DE69331652T2 publication Critical patent/DE69331652T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/04—Preparation by forming the ring or condensed ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69331652T 1992-11-13 1993-11-08 Azetidinonverbindung und Verfahren zu ihrer Herstellung Expired - Lifetime DE69331652T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP30366292 1992-11-13
JP11146093 1993-05-13
JP16918293 1993-07-08
JP23815593 1993-09-24

Publications (2)

Publication Number Publication Date
DE69331652D1 DE69331652D1 (de) 2002-04-11
DE69331652T2 true DE69331652T2 (de) 2002-10-17

Family

ID=27469913

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69331652T Expired - Lifetime DE69331652T2 (de) 1992-11-13 1993-11-08 Azetidinonverbindung und Verfahren zu ihrer Herstellung

Country Status (12)

Country Link
US (1) US5442055A (de)
EP (1) EP0597423B1 (de)
JP (1) JP2897153B2 (de)
KR (3) KR100231223B1 (de)
AT (1) ATE214061T1 (de)
CA (1) CA2102772C (de)
DE (1) DE69331652T2 (de)
DK (1) DK0597423T3 (de)
ES (1) ES2173087T3 (de)
IL (2) IL107532A (de)
PT (1) PT597423E (de)
SG (1) SG50416A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731431A (en) * 1991-12-26 1998-03-24 Nippon Soda Co., Ltd. Process for preparing 4-substituted azetidinone derivatives
US6011150A (en) * 1992-11-13 2000-01-04 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US5550229A (en) * 1993-06-23 1996-08-27 Tanabe Seiyaku Co., Ltd. Alkylation process for preparing azetidinone compound and starting compound therefor
DE69405922T2 (de) * 1993-06-30 1998-01-29 Tanabe Seiyaku Co Verfahren zur Herstellung von 4-substituierten Azetidinon-Derivaten
JPH09143156A (ja) * 1995-11-17 1997-06-03 Tanabe Seiyaku Co Ltd アセトキシアゼチジノン誘導体の製法及びその合成中間体
JP3450193B2 (ja) * 1998-07-24 2003-09-22 高砂香料工業株式会社 ４−置換アゼチジノン誘導体の製造方法
KR100377448B1 (ko) * 2000-08-10 2003-03-26 동화약품공업주식회사 카바페넴 항생물질의 중간체 및 그의 제조방법
JP2008056564A (ja) * 2004-11-12 2008-03-13 Shionogi & Co Ltd アゼチジノン誘導体の製造方法
AU2009277936B2 (en) 2008-07-30 2014-11-27 Sun Pharmaceutical Industries Limited Process for the preparation of carbapenem compounds
CA2774715C (en) 2009-07-27 2018-04-03 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
CN103096977B (zh) 2010-07-02 2017-02-15 吉利德科学公司 作为离子通道调节剂的稠杂环化合物
CA2834164A1 (en) 2011-05-10 2012-11-15 Gilead Sciences, Inc. Fused benzoxazinones as ion channel modulators
NO3175985T3 (de) 2011-07-01 2018-04-28
TWI478908B (zh) 2011-07-01 2015-04-01 Gilead Sciences Inc 作為離子通道調節劑之稠合雜環化合物
CN108774188A (zh) * 2018-07-23 2018-11-09 湖北宇阳药业有限公司 一种美罗培南中间体的制备方法
CN110025619B (zh) * 2019-04-29 2022-03-22 江苏汉阔生物有限公司 美罗培南中间体在制备抗氧化药物中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194047A (en) * 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
EP0010348A1 (de) * 1978-09-12 1980-04-30 Imperial Chemical Industries Plc Heterocyclische Trichlormethyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US4350631A (en) * 1980-12-18 1982-09-21 Merck & Co., Inc. 6- and 4-Substituted-1-azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylates
JPS5910570A (ja) * 1982-07-08 1984-01-20 Wakamoto Pharmaceut Co Ltd 新規イソカルボスチリル誘導体及びその製法
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
JPS615081A (ja) * 1984-06-18 1986-01-10 Sankyo Co Ltd １−置換カルバペネム−３−カルボン酸誘導体の製造法
DK270685A (da) * 1984-06-29 1985-12-30 Hoffmann La Roche Carbapenemderivater
JPS6225286A (ja) * 1985-07-26 1987-02-03 株式会社東芝 核融合装置用電源装置
EP0213610A1 (de) * 1985-08-31 1987-03-11 Lederle (Japan) Ltd. Azetidin-2-on-Derivate und Verfahren zu ihrer Herstellung
JPS6277384A (ja) * 1985-10-01 1987-04-09 Nippon Redarii Kk アゼチジン−２−オン誘導体及びその製造方法
JPS62252785A (ja) * 1986-01-08 1987-11-04 Sankyo Co Ltd ４−置換β−ラクタム化合物
JPS62169781A (ja) * 1986-01-21 1987-07-25 Sankyo Co Ltd β−ラクタム化合物
JP2789190B2 (ja) * 1986-01-27 1998-08-20 住友製薬株式会社 新規なβ−ラクタム誘導体およびその製造法
GB8607921D0 (en) * 1986-04-01 1986-05-08 Fujisawa Pharmaceutical Co 3,4-disubstituted-2-azetidinone derivatives
JP2510860B2 (ja) * 1987-02-02 1996-06-26 住友製薬株式会社 新規なβ−ラクタム誘導体の製造方法
JPS63284176A (ja) * 1987-05-15 1988-11-21 Nippon Redarii Kk （１ｒ，５ｒ，６ｓ）−６−〔（１ｒ）−１−ヒドロキシエチル〕−１−メチルカルバペネム−３−カルボン酸誘導体の高立体選択的製造方法
NO168304C (no) * 1988-04-01 1992-02-05 Sankyo Co Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-(heterocyklyltio)karbapenemderivater
JPH02178262A (ja) * 1988-12-28 1990-07-11 Sumitomo Pharmaceut Co Ltd １―（２′―ハロプロピオニル）ピロリジン―２―オン誘導体
JPH0662547B2 (ja) * 1989-01-10 1994-08-17 田辺製薬株式会社 グリシン誘導体
JPH02292269A (ja) * 1989-05-06 1990-12-03 Lederle Japan Ltd 活性アミド化合物
CA2050255C (en) * 1990-09-07 1997-02-04 Tameo Iwasaki 1-methylcarbapenem derivatives and process for preparation thereof
ATE202087T1 (de) * 1991-12-26 2001-06-15 Nippon Soda Co Verfahren zur herstellung von 4-substituierten azetidinon-derivaten

Also Published As

Publication number Publication date
SG50416A1 (en) 1998-07-20
PT597423E (pt) 2002-06-28
CA2102772C (en) 2001-04-03
DE69331652D1 (de) 2002-04-11
CA2102772A1 (en) 1994-05-14
ATE214061T1 (de) 2002-03-15
IL107532A (en) 1999-06-20
EP0597423A3 (de) 1995-04-12
KR100256863B1 (ko) 2000-05-15
KR100252404B1 (en) 2000-04-15
KR940011460A (ko) 1994-06-21
IL121842A0 (en) 1998-02-22
KR100231223B1 (ko) 1999-11-15
EP0597423B1 (de) 2002-03-06
JPH07165760A (ja) 1995-06-27
US5442055A (en) 1995-08-15
JP2897153B2 (ja) 1999-05-31
IL107532A0 (en) 1994-02-27
DK0597423T3 (da) 2002-05-21
ES2173087T3 (es) 2002-10-16
EP0597423A2 (de) 1994-05-18

Similar Documents

Publication Publication Date Title
DE69331652D1 (de) Azetidinonverbindung und Verfahren zu ihrer Herstellung
EP0422596A3 (en) Tricyclic carbapenem compounds
PT733621E (pt) Novos derivados de imidazole e processo para a sua preparacao
DE69129175T2 (de) 1-Methylcarbapenemderivate und Verfahren zu ihrer Herstellung
DE69313771T3 (de) Carbazolon - Derivate und Verfahren zu ihrer Herstellung
ATE141272T1 (de) Beta-lactam-verbindungen und ihre herstellung
EP0669336A4 (de) Neue cephem-derivate.
DE69227207T2 (de) 1-Piperazinyl-2-butene und 2-butyne, Zwischenverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69129790T2 (de) 5-Amino-5,6,7,8-Tetrahydrochinoline und verwandte Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69204480D1 (de) Anilinderivate und Verfahren zu ihrer Herstellung.
DE69212860D1 (de) Alpha-Methylencyclopentanon-Derivate und Verfahren zu ihrer Herstellung
ATE151422T1 (de) 8-azabicyclo(3.2.1>octylalkylthiazolidinone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA2027542A1 (en) Uv-absorbing cyclic enaminoketones
ATE95177T1 (de) Naphthothiazepin-derivate und verfahren zu ihrer herstellung.
DE69229017T2 (de) Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung
DE69711506T2 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition